Analysis Reveals Recent Acne Prescribing Trends Analysis Reveals Recent Acne Prescribing Trends
The study found that for women with acne, prescriptions for spironolactone increased about three- to fourfold during the study period among all clinician types.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - August 18, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Blood pressure pill that costs less than 1p could be a low-risk treatment for severe acne in women
Blood pressure medication spironolactone that costs less than a penny per pill could help banish severe acne in women. Kelly Cornick (pictured), 40, has been acne-free since starting three years ago. (Source: the Mail online | Health)
Source: the Mail online | Health - August 12, 2023 Category: Consumer Health News Source Type: news
Spironolactone Found to Improve Acne in Adult Women
WEDNESDAY, June 7, 2023 -- Spironolactone improves acne compared with placebo, with greater differences seen at week 24 than week 12, according to a study published online May 17 in The BMJ.
Miriam Santer, M.B., B.Chir., from the University of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 7, 2023 Category: Pharmaceuticals Source Type: news
Common Diuretic Pauses Atherosclerosis in CKD, T2D
(MedPage Today) -- AUSTIN, Texas -- The diuretic spironolactone stopped the progression of atherosclerosis in people with type 2 diabetes and chronic kidney disease (CKD), according to the MAGMA trial.
Among 79 patients with stages 3 to 4 CKD... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - April 15, 2023 Category: Urology & Nephrology Source Type: news
Monitoring Potassium in Individuals on Spironolactone Monitoring Potassium in Individuals on Spironolactone
Current guidelines recommend frequently checking the potassium levels of these individuals while taking spironolactone, but is it really necessary?Journal of the Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 29, 2022 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
Heart Failure Drug a New Treatment Option for Alcoholism? Heart Failure Drug a New Treatment Option for Alcoholism?
Spironolactone, a potassium-sparing diuretic typically used to treat heart failure and hypertension, has shown promise for alcohol use disorder, a common condition with few treatment options.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - September 27, 2022 Category: Psychiatry Tags: Psychiatry News Source Type: news
Heart drug shows promise as new alcoholism treatment, NIH says
Spironolactone, a widely used diuretic that treats heart problems and high blood pressure, may be an effective therapy for alcohol use disorder, new research suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 20, 2022 Category: Consumer Health News Source Type: news
Heart medication shows potential as treatment for alcohol use disorder
Spironolactone may play a role in reducing alcohol drinking. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - September 20, 2022 Category: American Health Source Type: news
Heart medication shows potential as treatment for alcohol use disorder
Spironolactone may play a role in reducing alcohol drinking (Source: NIDA News)
Source: NIDA News - September 20, 2022 Category: Addiction Tags: Alcohol, Treatment Research, News Release Source Type: news
No Sign Common Steroid Spironolactone Can Cause Cancer: Study
Title: No Sign Common Steroid Spironolactone Can Cause Cancer: StudyCategory: Health NewsCreated: 3/10/2022 12:00:00 AMLast Editorial Review: 3/10/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - March 10, 2022 Category: Cancer & Oncology Source Type: news
Spironolactone Use Not Linked to Increased Risk for Cancer
WEDNESDAY, Feb. 23, 2022 -- Spironolactone use is not associated with an increased risk for cancer, according to a systematic review and meta-analysis published online Feb. 9 in JAMA Dermatology.
Kanthi Bommareddy, M.D., from the University of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 23, 2022 Category: Pharmaceuticals Source Type: news
Data Review: Spironolactone Not Linked to Increased Cancer Risk Data Review: Spironolactone Not Linked to Increased Cancer Risk
The drug ' s antiandrogenic properties have driven its off-label use as a treatment for acne, hidradenitis, androgenetic alopecia, and hirsutism, and it is also used in gender-affirming care.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 22, 2022 Category: Cancer & Oncology Tags: Dermatology News Source Type: news
Hims & Hers dips into the female hair loss space
The company is now offering a topical Finasteride and Minoxidil spray as well as oral spironolactone through its virtual  care platform. (Source: mobihealthnews)
Source: mobihealthnews - January 14, 2022 Category: Information Technology Source Type: news
Janssen Showcases Commitment to Advancing Scientific Innovation in Pulmonary Arterial Hypertension (PAH) at CHEST 2021 Annual Meeting
TITUSVILLE, N.J. – October 14, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today 11* abstracts highlighting data from its pulmonary hypertension (PH) portfolio will be presented at CHEST 2021, the annual meeting of the American College of Chest Physicians, held virtually October 17-20.Data presentations from eight abstracts will provide additional evidence supporting the role of objective multiparameter risk assessment approaches in helping to optimize treatment and care for pulmonary arterial hypertension (PAH), as well as the impact of earlier and comprehensive therapy with UPTRAVIÂ...
Source: Johnson and Johnson - October 14, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
